FINWIRES · TerminalLIVE
FINWIRES

Alembic Pharmaceuticals Gets US FDA's Establishment Inspection Report for Karakhadi, India Unit

By

Alembic Pharmaceuticals (NSE:APLLTD, BOM:533573) has received an establishment inspection report from the US Food and Drug Administration (US FDA) for its injectable facility (F-III) at Karakhadi in Gujarat, India, according to a Thursday filing to the Indian stock exchanges.

The USFDA has inspected the facility between Feb. 9 and Feb. 18.

The company's shares were up nearly 2% in recent trade.

Related Articles

Asia

Matrimony.com's Consolidated Profit Rises in Fiscal Q4; Shares Up 5%

Matrimony.com's (NSE:MATRIMONY, BOM:540704) consolidated attributable profit rose to 97.1 million Indian rupees in the fiscal fourth quarter ended March 31, from 81.8 million rupees a year ago.Earnings per share came in at 4.59 rupees from 3.79 rupees a year earlier, according to a Wednesday filing to the Indian stock exchanges on Thursday.Revenue from operations also increased to 1.17 billion rupees from 1.08 billion rupees a year ago.The company's board declared a final dividend of 5 rupees per share of 5 rupees each. The record date for the dividend has been set as Aug. 5.Matrimony.com's shares were up nearly 5% in recent trade.

$BOM:540704$NSE:MATRIMONY
Asia

Destini Secures Five-Year Contract for Malaysia Tubular Service from Petronas Carigali

Destini (KLSE:DESTINI) unit Destini Oil Services bagged a contract from Petronas Carigali to provide tubular running services in the West Region of Malaysia.The contract runs for five years from March 30, 2026, to March 29, 2031, with the value to be determined based on work orders issued.The deal is expected to contribute positively to earnings and net assets for the financial year ending June 2026, it said.

$KLSE:DESTINI
Asia

S&P Raises CDB Aviation Lease Finance Designated Activity's Standalone Credit Profile

S&P Global Ratings upgraded CDB Aviation Lease Finance Designated Activity's standalone credit profile to "bb-" from "b+" while maintaining its A long-term issuer credit rating, according to a recent release.The company sees improved debt maturity profile and EBIT interest coverage due to long-term debt issuances, a capital injection, and increased rental yields, S&P said.The outlook is stable for the next two years, reflecting that on parent China Development Bank Financial Leasing (HKG:1606) and S&P's view that the subsidiary will continue to be a core subsidiary of the parent.The affirmed rating considers the parent's support, especially for the aircraft lessor's business development and funding needs, as reflected in a $860 million capital injection.S&P does not expect further injections in the next 12 to 24 months, due to the lessor's own cash flow and further US dollar financing that would be enough for future capacity additions.The rating agency expects long-term aircraft demand to remain strong despite a temporary slowdown due to the Middle East impact.

$HKG:1606